Abstract
Non pharmacological treatment, in addition to pharmacological treatment is indicated in patients with refractory/pharmacoresistant epilepsy and includes ketogenic diet, deep brain stimulator, vagal nerve stimulator, transcranial magnetic stimulation and epilepsy surgery. Ketogenic diet has been recommended since 1921 and has been proved to be a safe and effective treatment for intractable epilepsy. Deep brain stimulator, has been used in the treatment of movement disorders for many years and recently been tried in the treatment of pharmacoresistant epilepsy. Vagus nerve stimulator is increasingly being used as an effective seizure aborting technique in patients not responding to anticonvulsants. Transcranial magnetic stimulation is a noninvasive brain stimulation technique which is being increasingly researched for use in patients with medication-refractory seizures who are not suitable candidates for surgery. Evolution of epilepsy surgery including Vagal nerve stimulator and Deep brain stimulator, as a successful treatment modality for intractable epilepsy has been influenced over the last decade by substantial advancement in imaging and operative/device related technology. The current article reviews the indications, mechanism of action, technological aspects and efficacy of the aforementioned modalities in the treatment of intractable/pharmacoresistant epilepsy in pediatric age group.
Similar content being viewed by others
Abbreviations
- SUDEP:
-
Sudden Unexpected Death in Epilepsy
- AED:
-
Antiepileptic Drugs
- KD:
-
Ketogenic Diet
- GABA:
-
Gamma Aminobutyric Acid
- VNS:
-
Vagal Nerve Stimulator
- DBS:
-
Deep Brain Stimulator
- TMS:
-
Transcranial Magnetic Stimulation
- RNS:
-
Responsive Cortical Neuro-Stimulator
- EEG:
-
Electroencephalogram
- SPECT:
-
Single –Photon Emission Computed Tomography
- PET:
-
Positron Emission Tomography
- MRI:
-
Magnetic Resonance Imaging
References
Fisher RS, Parks-Trusz SL, Lehman C. Social issues in epilepsy. In: Shorvon S, Dreifuss F, Fish D, et al., editors. The treatment of epilepsy. Woburn: Blackwell Science; 1996.
French JA. Refractory epilepsy: clinical overview. Epilepsia. 2007;48:S3–7.
Bible. The New King James Version Mark 9:14–29. Carmel, NY: Guideposts; 1982.
Li B, Tong L, Jia G, Sun R. Effects of ketogenic diet on the clinical and electroencephalographic features of children with drug therapy-resistant epilepsy. Exp Ther Med. 2013;5:611–5.
Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008;7:500–6.
Freeman JM. The ketogenic diet: additional information from a crossover study. J Child Neurol. 2009;24:509–12.
Noh HS, Kim YS, Lee HP, Chung KM, Kim DW, Kang SS, et al. The protective effect of a ketogenic diet on kainic acid-induced hippocampal cell death in the male ICR mice. Epilepsy Res. 2003;53:119–28.
Gasior M, Rogawski MA, Hartman AL. Neuroprotective and disease-modifying effects of the ketogenic diet. Behav Pharmacol. 2006;17:431–9.
Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK, Rho JM. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann Neurol. 2004;55:576–80.
Kossoff EH, Zupec-Kania BA, Amark PE, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R, et al. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia. 2009;50:304–17.
Kilaru S, Bergqvist AG. Current treatment of myoclonic astatic epilepsy: clinical experience at the Children’s Hospital of Philadelphia. Epilepsia. 2007;48:1703–7.
Kossoff EH, Thiele EA, Pfeifer HH, McGrogan JR, Freeman JM. Tuberous sclerosis complex and the ketogenic diet. Epilepsia. 2005;46:1684–6.
Kossoff EH, Hedderick EF, Turner Z, Freeman JM. A case- control evaluation of the ketogenic diet versus ACTH for new- onset infantile spasms. Epilepsia. 2008;49:1504–9.
Wheless JW. The ketogenic diet. In: Swaiman KF, Ashwal S, Ferriero DM, Schor N, editors. Swaiman’s pediatric neurology-principles and practice. 5th ed. Philadelphia: Elsevier; 2012. p. 836–53.
Takeoka M, Riviello Jr JJ, Pfeifer H, Thiele EA. Concomitant treatment with topiramate and ketogenic diet in pediatric epilepsy. Epilepsia. 2002;43:1072–5.
Wheless JW. The ketogenic diet: an effective medical therapy with side-effects. J Child Neurol. 2001;16:633.
Kossoff EH, Zupec-Kania BA, Rho JM. Ketogenic diets: an update for child neurologists. J Child Neurol. 2009;24:979–88.
Kossoff EH, McGrogan JR, Bluml RM, Pillas DJ, Rubenstein JE, Vining EP. A modified atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia. 2006;47:421–4.
Sharma S, Sankhyan N, Gulati S, Agarwala A. Use of the modified atkins diet for treatment of refractory childhood epilepsy: a randomized controlled trial. Epilepsia. 2013;54:481–6.
Sharma S, Sankhyan N, Gulati S, Agarwala A. Use of the modified atkins diet in infantile spasms refractory to first-line treatment. Seizure. 2012;21:45–8.
Lipsman N, Ellis M, Lozano AM. Current and future indications for deep brain stimulation in pediatric populations. Neurosurg. 2010;29:E2.
Fisher RS. Deep brain stimulation for epilepsy. Handb Clin Neurol. 2013;116:217–34.
Cukiert A, Burattini JA, Cukiert CM, Argentoni-Baldochi M, Baise-Zung C, Forster CR, et al. Centro-median stimulation yields additional seizure frequency and attention improvement in patients previously submitted to callosotomy. Seizure. 2009;18:588–92.
Chambers A, Bowen J. Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis. Ont Health Technol Assess Ser. 2013;13:1–37.
Fisher R, Salanova V, Witt T, Worth R, Henry T, Gross R, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia. 2010;51:899–908.
Burn DJ, Tröster AI. Neuropsychiatric complications of medical and surgical therapies for parkinson’s disease. J Geriatr Psychiatry Neurol. 2004;17:172–80.
Cyberonics, Inc. VNS therapy products manuals and safety alerts: Part I - Introduction - indications, warnings, and precautions, p. 7–13. Available at: http://dynamic.cyberonics.com/manuals/
Groves DA, Brown VJ. Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Neurosci Biobehav Rev. 2005;29:493–500.
Rutecki P. Anatomical, physiological, and theoretical basis for the antiepileptic effect of vagus nerve stimulation. Epilepsia. 1990;31:S1–6.
Zabara J. Inhibition of experimental seizures in canines by repetitive vagal stimulation. Epilepsia. 1992;33:1005–12.
DeGiorgio C, Heck C, Bunch S, Britton J, Green P, Lancman M, et al. Vagus nerve stimulation for epilepsy : randomised comparison of three stimulation paradigm. Neurology. 2005;65:317–9.
The Vagus Nerve Stimulation Study Group. A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. Neurology. 1995;45:224–30.
Ben-Menachem E, Manon-Espaillat R, Ristanovic R, Wilder BJ, Stefan H, Mirza W, et al. Vagus nerve stimulation for treatment of partial seizures: a controlled study of effect on seizures. First Int Vagus Nerve Stimulation Study Group. Epilepsia. 1994;35:616–26.
Kabir SM, Rajaraman C, Rittey C, Zaki HS, Kemeny AA, McMullan J. Vagus nerve stimulation in children with intractable epilepsy: indications, complications and outcome. Childs Nerv Syst. 2009;25:1097–100.
Klinkenberg S, Aalbers MW, Vles JS, Cornips EM, Rijkers K, Leenen L, et al. Vagus nerve stimulation in children with intractable epilepsy: a randomized controlled trial. Dev Med Child Neurol. 2012;54:855–61.
Elliott RE, Rodgers SD, Bassani L, Morsi A, Geller EB, Carlson C, et al. Vagus nerve stimulation for children with treatment-resistant epilepsy: a consecutive series of 141 cases. J Neurosurg Pediatr. 2011;7:491–500.
Hallbook T, Lundgren J, Stjernqvist K, Blennow G, Stromblad LG, Rosen I. Vagus nerve stimulation in 15 children with therapy resistant epilepsy; its impact on cognition, quality of life, behaviour and mood. Seizure. 2005;14:504–13.
Cascino GD, Theodore WH. Epilepsy surgery and electronic devices. Continuum (Minneap Minn). 2010;16:179–98.
Chen R, Classen J, Gerloff C, Celnik P, Wasserman EM, Hallett M, et al. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology. 1997;48:1398–403.
Joo EY, Han SJ, Chung SH, Cho JW, Seo DW, Hong SB. Antiepileptic effect of low frequency repetitive transcranial magnetic stimulation by different stimulation durations and locations. Clin Neurophysiol. 2007;118:702–8.
Sun W, Mao W, Meng X, Wang D, Qiao L, Tao W, et al. Low-frequency repetitive transcranial magnetic stimulation for the treatment of refractory partial epilepsy: a controlled clinical study. Epilepsia. 2012;53:1782–9.
Wasserman EM. Safety and side effects of transcranial magnetic stimulation and repetitive transcranial magentic stimulation. In: Pascual-Leone A, Davey NJ, Rothwell J, editors. Handbook of transcranial magnetic stimulation. London: Arnold; 2002. p. 39–49.
Schulze-Bonhage A, Scheufler K, Zentner J, Elger CE. Safety of single and repetitive focal transcranial magnetic stimuli as assessed by intracranial EEG recordings in patients with partial epilepsy. J Neurol. 1999;246:914–9.
Kwan P, Brodie MJ. Early identification of refractory epilepsy. New Engl J Med. 2000;342:314–9.
Zupanc ML, Rubio EJ, Werner R, Schwabe MJ, Mueller WM, Lew SM, et al. Epilepsy surgery outcomes: quality of life and seizure control. Pediatr Neurol. 2010;42:12–20.
Sinclair BD, Aronyk KE, Snyder TJ, Wheatley BM, McKean JD, Bhargava R, et al. Pediatric epilepsy surgery at the University of Alberta: 1988–2000. Pediatr Neurol. 2003;29:302–11.
Paolicchi JM, Jayakar P, Dean P, Yaylali I, Morrison G, Prats A, et al. Predictors of outcome in pediatric epilepsy surgery. Neurology. 2000;54:642–7.
Wiebe S, Blume WT, Girvin JP, Eliasziw M; Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345:311–8.
Ahmad FU, Tripathi M, Padma MV, Gaikwad S, Gupta A, Bal CS, et al. Health-related quality of life using QOLIE-31: before and after epilepsy surgery a prospective study at a tertiary care center. Neurol India. 2007;55:343–8.
Bourgeois B. General concepts of medical intractability. In: Luders HO, editor. Epilepsy surgery. New York: Raven; 1991. p. 77–81.
Harvey H, Cross JH, Shinnar S, Mathern GW. ILAE pediatric epilepsy surgery survey taskforce. Defining the spectrum of international practice in pediatric epilepsy surgery patients. Epilepsia. 2008;49:146–55.
Wyllie E, Lachhwani DK, Gupta A, Chirla A, Cosmo G, Worley S, et al. Successful surgery for epilepsy due to early brain lesions despite generalized EEG findings. Neurology. 2007;69:389–97.
Korkman M, Granström ML, Kantola-Sorsa E, Gaily E, Paetau R, Liukkonen E, et al. Two-year follow-up of intelligence after pediatric epilepsy surgery. Pediatr Neurol. 2005;33:173–8.
Danielsson S, Rydenhag B, Uvebrant P, Nordborg C, Olsson I. Temporal lobe resection in children with epilepsy: neuropsychiatric status in relation to neuropathology and seizure outcome. Epilepsy Behav. 2002;3:76–8.
Meyer FB, Marsh WR, Lawa ER, Sharbrough FW. Temporal lobectomy in children with epilepsy. J Neurosurg. 1986;64:371–6.
Vigevano F, DiRocco C. Effectiveness of hemispherectomy in hemimegalencephaly with intractable seizures. Neuropediatrics. 1990;21:222–3.
Spencer SS, Schramm J, Wyler A, O’Connor M, Orbach D, Krauss G, et al. Multiple subpial transaction for intractable partial epilepsy: an international meta analysis. Epilepsia. 2002;43:141–5.
Maehara T, Shimizu H. Surgical outcome of corpus callosotomy in patients with drop attacks. Epilepsia. 2001;42:67–71.
Morell MJ; RNS System in Epilepsy Study Group. Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology. 2011;77:1295–304.
FDA news release: Nov. 14, 2013. Available at http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm375041.htm
Conflict of Interest
None.
Source of Funding
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Parakh, M., Katewa, V. Non-Pharmacologic Management of Epilepsy. Indian J Pediatr 81, 1073–1080 (2014). https://doi.org/10.1007/s12098-014-1519-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-014-1519-z